Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare ...

The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...

The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs ...

In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

Expanding eligibility for MSPs is an important avenue to support health care affordability for older low-income adults, ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.